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Abstract
Background: Gonorrhea is a major sexually transmitted disease worldwide and for its control, effective treatment is essen-
tial. However as more strains of  Neisseria gonorrhoeae continuously develop resistance to several drugs, this strategy obliges 
scientists to discover newer effective drugs.
Objectives: To ascertain whether crude leaf  and root extracts of  Cassia alata (Caesalpiniaceae) have antimicrobial activity 
against clinically resistant Neisseria gonorrhoeae bacteria. To determine and compare the MICs of  their ether and methanol 
extracts.
Materials and methods: Ether and methanol extracts were prepared from the plant parts. 12-375mg/ml of  serially diluted 
ether extracts in DMSO and methanol extracts in water were tested using agar-well diffusion method against Neisseria gon-
orrhea clinical isolate cultured on MTM agar. MICs were determined from corresponding concentration-response curves. 
Ceftriaxone was used as positive control, whereas DMSO and water as negative controls.
Results: All the crude extracts showed concentration-dependent Neisseria gonorrhea inhibition. Ether extracts for both 
leaves and roots gave lower MICs compared to those of  methanol. Ether root extract showed the highest potency.
Conclusions: Both the leaf  and the root of  Cassia alata plant have activity against clinically resistant Neisseria gonorrhoeae; 
the root having the higher activity. Lipophilic solvent, ether, give more potent antigonorrhoeal extracts. As expected Cassia 
alata plant in Central Uganda also has antibacterial activity. 
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Introduction
Gonorrhea  is  a  purulent  infection  of   mucous  mem-
brane  surfaces  caused  by  Neisseria gonorrhoeae bac-
teria. According to the World Health Organization ap-
proximately 62 million new cases of  gonorrhea disease 
occur globally each year1. The bacteria infect principally 
the urethra in men and endocervix in women. It may 
also infect extra-genital mucosal sites including the oro-
pharynx, anorectum and ocular membranes. Genital 
infections in men usually present with a urethral dis-
charge but asymptomatic infections and extra-genital 
infections are more common in women. However dis-
seminated Gonoccocal Disease (DGI) is a rare occur-
ance2.
There are three laboratory tests available for diagnosis 
of  gonorrhea: gram staining, culturing and nucleic acid 
amplification tests3,4. In Uganda, diagnosis of  gonorrhea 
is usually done clinically, based on patients’ symptoms 
and since gonorrhea is usually asymptomatic especially 
in women, most cases go undetected. There is an in-
creasing rise in resistance to drugs used for treatment 
of  gonococcal infections with most patients left poorly 
treated5-10. Poorly treated or undetected gonorrhea can 
cause complications like pelvic inflammatory disease in 
women; which can lead to ectopic pregnancy and infer-
tility; and epididymitis and prostatitis in men4,9,11. These 
complications need prolonged treatment that becomes 
very expensive and often unattainable by resource lim-
ited  countries including Uganda. Infections with gon-
orrhea have also been associated with increased Human 
immunodeficiency virus (HIV) shedding, which can 
lead to increased incidence of  the HIV infections12.
These coupled with the high incidences of  adverse drug 
African Health Sciences Vol 14 Issue 4, December 2014
reactions (ADRs) of  the current drugs used in treat-
ing gonorrhea, calls for urgency in looking for alterna-
tive sources of  potential antibacterial drugs, especially 
among plant species.
 
Medicinal plants have been used widely around the 
world to treat various infectious diseases and ailments, 
with the World Health Organization (WHO) estimat-
ing that 65-80% of  the world’s population living in de-
veloping countries use these plants for primary health 
care13.
Cassia alata, also known as ringworm bush, candle bush, 
candle stick and empress candle, is an erect annual herb 
that grows 3-4 meters tall and has dark green leathery 
compound leaves on stout branches. It was originally 
from South America but spread throughout the pan-
tropics14. Uganda, being a tropical country, has this 
plant growing wildly, and in abundance.
This  plant;  especially its  leaves  is  widely used  in 
tropical  regions  as  home  remedies  and sometimes 
cultivated for medicinal purposes. The uses includes: 
ayurvedic medicine, treatment of: constipation, stom-
ach pain, ringworm, skin disease, inguinal hernia, in-
testinal parasitosis and diabetes. The antimicrobial ac-
tivity reported is diverse, acting on; bacteria, fungi and 
amoeba15-26. Though it has been used blindly in treating 
syphilis23, the specific bacteria against which the leaves 
have been found to be active are: Vibrio cholerae, Ba-
cillus subtilis, Staphylococcus aureus, Streptococcus sp. 
and Escherichia coli 25. Few studies ventured to check 
its activity against gonorrhea, the disease but not on the 
bacterium Neisseria gonorrhoea, and they only exam-
ined the leaves. 
 
This present study was undertaken to determine the in-
vitro antibacterial activity of  crude ether and ethanol 
leaf  as well as root extracts of  Cassia alata on Neisseria 
gonorrhea and to determine the minimum inhibitory 
concentrations (MICs) of  the extracts. The few docu-
mented actions of  this plant against gonorrhea were 
about this plant and its efficacy or effectiveness in treat-
ment of  the clinical disease; without checking the bacte-
ria themselves in-vitro. Unlike those studies, this study 
used gonococcal isolates and assessed the action of  this 
plant against the bacteria. In addition, the bacteria used 
were a clinical isolate from a resistant case.
Whereas the previous studies focused on the leaves, 
this study included the roots and compared their ac-
tivity with that of  the leaves. Furthermore the previ-
ous studies did not emphasize the importance of  the 
lipophilicity or hydrophilicity of  the solvents used on 
the potency of  extracts got; this study did and found 
out which solvent gave a more potent antibacterial ex-
tracts of  the plant parts.
 
Besides from this study one can demonstrate whether 
Cassia alata from some part of  Uganda and her envi-
ronmental conditions are similar to other Cassia alata 
plants in the world, in that it also has antibacterial activ-
ity; albeit only one bacterial species was studied. Ad-
ditionally from this study one can conclude about the 
qualitative difference or the similarity in the antibacte-




Plant Collection and Identification Extraction Fresh 
whole-leaves and whole-roots of  Cassia alata were col-
lected from Mukono district, central Uganda, during 
the month of  January 2011. For purposes of  ensuring 
correct botanical identification, the plant  herbarium 
specimen was prepared and  submitted to  the Univer-
sity herbarium, Department of  Botany, School of  Bio-
Sciences, College of  Natural Sciences, Makerere Uni-
versity, Uganda, for authentication.
                       
Preparation of  extracts
The whole-leaves and whole-roots of  the plant were 
washed in water and air-dried under a shade for a period 
of  two weeks after which they were ground to powders 
with a mechanical grinder.
190g of  the root powder and 300g of  the leaf  powder 
were macerated separately at room temperature with oc-
casional shaking using ether as the solvent for 24 hours 
after which the extract was decanted and filtered using 
a Whatman’s No 1 filter paper. The procedure was re-
peated twice at the end of  which the marc was left to 
dry to remove more traces of  the solvent. The above 
process was repeated this time using methanol. In each 
case the obtained concentrates were then transferred to 
pre-weighed Petri dishes and allowed to dry in a warm 
oven (about 37OC), until constant weight was got – this 
took about six hours. The dried extracts were kept in 
the dried oven and used within five days in screening 
the extracts for antibacterial activity described far be-
low. 
Test bacteria and culture media
A urethral swab was obtained from a chronic resistant 
case at Uganda, Mulago National Referral and  Teach-
ing hospital, sexually transmitted diseases clinic,  in  an 
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ethical  manner, with  the assistance of  the laboratory 
of  Department of  Microbiology, College of  Health 
Sciences, Makerere University, Uganda. The urethral 
swab was used to  inoculate a  freshly prepared Modi-
fied Thayer-Martin agar, and the inoculum was spread 
using a sterile loop, across the entire plate surface in a 
Z-pattern.
The inoculated plate was incubated immediately at 35-
37°C in 3-5% carbon dioxide (CO2) for 48-56 hrs. The 
resultant growth (colonies) was used in two ways: Some 
was spent (without further re-isolation or passage) in 
making the cell suspension used during screening the 
extracts for antibacterial activity as described below, 
whilst some was used in Gram-stained smears to reveal 
the characteristic gram negative diplococcic, as a way of  
confirming that the growth is actually N. gonorrhoeae.
All the MTM agars used were prepared using Faur YC 
et al., 1973, NYC medium preparation method with 
slight modifications27. Instead of  the horse blood, sheep 
blood was used. The sheep were from the School of  
veterinary and animal resources, college of  veterinary 
medicine, animal resources and bio-security (COVAB), 
Makerere university, Uganda. The components used in 
the preparation included: Thayer Martin Medium Base 
(Oxoid Ltd), and the following antimicrobials: Vanco-
mycin (Biolab Zrt), Colistin (BD & Co), Nystatin (Bio-
lab Zrt) and Trimethoprim (BD & Co). 
 
Screening extracts for antibacterial activity
The antibacterial activity screening used was the agar-
well diffusion method used by Okunji et al., 1990 and 
Okeke et al., 200128-29, but changed to using a bigger 
well diameter, because the suitable well boring instru-
ment was that big.
The dried leaf  and root extracts were reconstituted in 
two different solvents; double-distilled water (made lo-
cally from our laboratory in Pharmacy Department) 
and DMSO (Sigma) (pure). Different quantities of  the 
ether and methanol extracts were dissolved in different 
quantities of  DMSO and water respectively to give final 
concentrations of  375, 187.5, 93.75, 46.875, 23.438 and 
11.719mg/ml of  the leaf  and root extracts – see Table 
2 below. Ceftriaxone (BioLab.) 100µg/ml, was included 
as a positive control while DMSO (100%) and water 
served as negative controls  –  see  Table  1  below.  
Fifteen  fresh  plates  of   MTM  agar  were  brought 
to  room temperature and  to  be  used  as  follows: six 
plates  for  varying concentrations of   ether  and metha-
nol leaf  extracts, another six for ether and methanol 
root extracts and the remaining three for the negative 
and positive controls. Using a sterile loop isolated colo-
nies of  Neisseria gonorrhoeae were added to 4mls of  
sterile normal saline and the saline stirred using a ster-
ile stainless steel rod. The addition of  the colonies and 
stirring was repeated until the saline solution became 
turbid. A sterile swab was dipped into the stirred turbid 
cell suspension then used to inoculate the entire surface 
of  the MTM plates by seeding first horizontally then 
vertically and left to dry/settle while covered at room 
temperature for about 30 min.
After the drying, two wells, 10mm diameters each were 
bored in each plate with an aseptic cork borer. As soon 
as the wells were prepared, they were filled with 200µl 
of  extracts and controls using a sterile pipette. All these 
together were left to stand in a sterile environment for 
1 hour to let the extracts diffuse into the agar before 
incubation. 
After incubating the plates at 35-37°C at  3-5% ofCO2 
for 32-8hrs., diameters of  zones of  inhibition were 
measured using a calibrated ruler. For each concentra-
tion, three replicates were used and the corresponding 
mean diameter and thus radius of  zone of  inhibition 
calculated.
Determination of  Minimum Inhibitory Concentra-
tions of  the extracts
A plot of  the square of  the radius diameter of  the zones 
of  inhibition against log concentration of  the dilutions 
was done and a suitable curve drawn from the plots for 
each extract. Extrapolation of  the curve was done to 
determine the log of  MIC. From this log the MIC was 
calculated as the antilog. 
 
Results
Table 1 shows the radii of  zones of  inhibition of  Cef-
triaxone (positive control) and of  water and DMSO 
(negative controls). Table 2 shows the different concen-
trations of  the crude leaf  and root ether and methanol 
extracts and their corresponding radii of  zones of  in-
hibition. Table 3 shows the different log concentrations 
of  the crude leaf  and root ether and methanol extracts 
and their corresponding square of  the radii of  zones of  
inhibition.
The negative controls i.e. the solvents; DMSO and wa-
African Health Sciences Vol 14 Issue 4, December 2014
ter had no inhibition of  the bacteria, whereas the posi-
Table 1: Antibacterial activity of 
controls 
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tive control i.e. the Ceftriaxone had marked inhibition 
of  the gonococci.
Table 2: Antibacterial activity of crude plant extracts 
 
Showing radius of zones of inhibition with concentration of crude plant extracts 
 
 
Final  Concentration 
 












  Ether Methanol Ether Methanol 
11.719 1.069 02.09 00.00 00.00 00.00 
23.438 1.370 03.67 00.00 00.00 00.00 
46.875 1.671 05.00 00.00 00.84 00.00 
93.75 1.972 06.09 00.92 02.17 00.84 
187.5 2.268 07.25 02.00 03.67 02.25 
375 2.574 08.34 03.67 07.17 03.25 
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NB: 1mg/ml ≡ 1 µg/µl.
Mean radius (mm), X = [{Mean diameter – inclusive of  
well diameter (mm)} – {Well diameter (10mm)}] / 2. 
NB: 1mg/ml ≡ 1µg/µl.
Table 3: Antibacterial activity of crude plant extracts 
 
Showing logs concentration against X2 (mm2) for crude plant extracts 
 
 
Final  Concentration 
 











      
  Ether Methanol Ether methanol 
11.719 1.069 04.347 00.000 00.000 00.000 
23.438 1.370 13.432 00.000 00.000 00.000 
46.875 1.671 25.000 00.000 00.697 00.000 
93.75 1.972 37.027 00.837 04.687 00.706 
187.5 2.268 52.563 04.000 13.432 05.063 
 
375 2.574 69.472 13.432 51.337 13.432 
Where X mm= [{Mean diameter – inclusive of  well diameter (mm)} – {Well diameter (10mm)}]/ 2. NB: 
Figure 1: Showing Excel plots of  logs concentration against X2  (mm2) for the crude plant extracts 
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1mg/ml ≡ 1 µg/µl.
The X-intercepts were got from equations of  the trend 
lines from excel plotsof  X2against Log concentrations 
of  crude extracts (leaving out the coordinates with 0 
values of  X2  ) and used to calculate the MICs in the 
table 4 below.
Table 4: Antibacterial activity of  crude plant extracts showing MICs of  the crude plant extracts 
From the Figure 1 and Tables 2, 3 & 4 above, it could 
be observed that there was concentration- dependent 
inhibition of  the gonococci. The methanol extracts of  
both the leaves and roots had similar inhibition poten-
cies and were lower than those of  the ether extracts. 
The roots-ether extract had the highest potency of  the 
inhibition at the concentrations used and a linear re-
lationship of  the X2 with the log concentration. The 




Both the ethereal and methanolic leaf  and root extracts 
of  Cassia alata exhibited variable antibacterial activity 
against the clinical isolate of  Neisseria gonorrhoeae. 
However, the ether extracts generally exhibited better 
antibacterial activity as compared to the methanol ex-
tracts; Compare the positions of  the curves in Figure 1 
and MICs in Table 4.
Differences in activities of  extracts from different sol-
vents are not new, and for Cassis alata extracts it had 
also been observed in other solvents19-22. From previous 
studies, and since ether is more organic than methanol 
solvent, the ethereal extracts were as expected to be 
more active than the methanol extracts19,21,22.  In this 
study the superiority of  the activity of  the solvents 
observed was as expected; ethereal extracts were more 
active than methanolic extracts. The greater activity of  
the ethereal extracts versus the methanolic extracts may 
suggest any one of  the following:
First, the  active  principles  responsible for  the  an-
tibacterial activity could  be  identical  in structures in 
both extracts, only that they could be more soluble in 
ether than in methanol i.e. perhaps they are more lipo-
philic.
Secondly, the active principles could be different in 
structures and those extracted by ether are perhaps more 
potent compared to those extracted by methanol.
Thirdly, there could be impurities that are more soluble 
in methanol than in ether which may be responsible for 
the lower activity by diluting the active principles in the 
methanolic extract. Lastly,  maybe  there  are  different 
impurities  with  different  antagonism  against  the  ac-
tive principles  and  those  impurities  dissolved  by  the 
ether  extracts  could  be  less  antagonistic compared to 
those taken up by methanol. 
 
Conversely one may argue that compared to the leaves, 
the roots maybe had more amounts of  active principles, 
or more potent active principles, or less antagonistic 
impurities.
Distribution of  active principles within a plant vary 
from part to part of  the plant and this was also wit-
nessed in Cassia alata19,20,22.  This may explain why the 
ethereal root extract showed higher antibacterial ac-
tivities at all the concentrations compared to the leaf  
extract of  the same solvent, ether. Suggesting that the 
active principles maybe the same but are probably more 
concentrated in the roots than in the leaves. It can also 
be that the chief  active principle(s) in the two parts of  
the plants are actually different in structures and poten-
cies.
Cassia alata, being a  tropical plant and also Mukono, 
Uganda, from where the plant was collected being geo-
graphically tropical, one could not expect absence of  
antimicrobial activity, albeit  qualitatively,  since  previ-
ous  studies  had  found  them25-2625-26.    This  was 
predictable  as explained by, arguably, a comparative 
study by Zouari et al., 2012,30.
 X – Intercept of the Extracts MIC (mg/ml OR µg/µl) of the Extracts 
Plant Part Ether Methanol Ether Methanol 
Roots 1.043 1.975 11.0 94.4 
Leafs 1.925 1.969 84.1 93.1 
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Getting antibacterial activity in the plant in this study, 
without concern in the phenological stage of   the  plant 
could  have well  been  by  chance, because plant  com-
ponents and  antibacterial activities can differ depend-
ing on the phenological stage of  the plant, as illustrated 
by the study of  Nejad Ebrahimi et al., 2008,31. It could 
also be that this plant Cassia alata, makes substantial 
amounts of  antibacterial components at whatever phe-
nological stage of  its life.
Ceftriaxone (positive control), the standard therapeu-
tic agent, exhibited greater antibacterial activity against 
Neisseria gonorrrhoeae (38.00mm) as  compared to 
both  the  root  and  leaf  extracts of  Cassia alata. This 
is to be expected since the extracts have various impuri-
ties as compared to the drug that is a purified syntheti-
cally processed molecule20,21. Also the concentration 
used was high. 
 
Conclusion
Both leaf  and root extracts of  Cassia alata have anti-
bacterial activity against Neisseria gonorrhoeae, but the 
root extracts are more potent than the leaf  extracts, ir-
respective of  the solvent used for the extraction.
However using non-polar solvents, like ether for ex-
traction, most likely give rise to more potent extracts 
against the bacteria.
Since both the roots and the leaves of  the plant have 
antigonococcal activity, other parts of  the plant may 
also have the antigonococcal activity.
The study also confirms the validity of  the use of  the 
plant in traditional medicine for the treatment of  gono-
coccal infections.
Any Cassia alata plant, growing anywhere within the 
tropics most likely have some antibacterial activity, pro-
vided the plant parts are harvested at the right pheno-
logical stage or stages. 
 
Recommendations
This is the first study of  its kind in Uganda ascertaining 
the in-vitro antibacterial activity of  Cassia alata crude 
extracts against Neisseria gonorrhoeae.
More different solvents, conditions and types of  ex-
tractions should be performed on different parts of  the 
plants and their corresponding extracts studied again 
on the gonococci, so as to find the best solvent for ex-
traction of  the plant, and the most active part of  the 
plant for optimal utilization of  the plant crudely or for 
isolation of  the active ingredients.
Other resistant gonorrhea strains and isolates and bac-
teria species should also be tested for antagonism by 
this plant.
If  the possible the active components should be isolated 
and elucidated to ascertain whether it is a new antimi-
crobial agent or not, followed by clinical and toxicologi-
cal studies. This will pave the way for continuation with 
advanced drug development thus widening the scope 
of  drug- based treatment of  infectious diseases.
In line with conservation efforts, the lipophilic active 
ingredients from both roots and leaves, obtained by us-
ing a wider range of  lipophilic solvent systems, should 
be structure elucidated and assessed for antibacterial 
activity.  Depending on the results, the raw material for 
further drug processing and development should be ob-
tained from the leaves and not roots as the latter leads 
to destruction of  the plants at harvest.
Studies should be done to find out the best phenologi-
cal stage(s) of  the Cassia alata plant for harvesting that 
give rise to the most potent and best antimicrobial ac-
tivities. Knowing the best phenological stage can result 
in the plant being used sparingly, since small amounts 
would be enough for treatment.
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